Patent US5116596A successfully refreshed from Google Patents.
US5116596A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for the preparation of an organ-specific substance labeled with technetium-99m
Assignee: CIS Bio International SA
•
Filing: 1989-10-27
•
Granted: 1992-05-26
•
Expires: 2009-10-27
Abstract
Abstract The invention relates to a process for the preparation of an organ-specific substance labeled with technetium-99m, in which an organ-specific substance, or an organ-specific substance which has been pretreated or coupled to a complexing agent for technetium-99m, is mixed with [99m]-pertechnetate and a complex-stabilized reducing agent.
Inventors
- 👤 Karl-Heinz Bremer
- 👤 Ludwig Kuhlmann
- 👤 Alexander Schwarz
- 👤 Axel Steinstrasser
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 05:49
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/08; A61K51/12; A61K51/10; A61K51/1045; A61K51/1048; A61K51/1057; A61K2123/00; Y; Y10; Y10S; Y10S530/00; Y10S530/866
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
65 words
A test kit comprising two separate freeze-dried components, one of which contains an organ-specific substance which has been pretreated in order to generate at least one functional group having complexing properties in the molecule of the organ-specific substance, and the other component contains a reducing agent which is required for the reduction of 99m pertechnetate and subsequent binding of technetium-99m to the pretreated organ-specific substance.
Claim 2
Dependent Claim
65 words
A test kit comprising two separate freeze-dried components, one of which contains an organ-specific substance which has been pretreated in order to generate at least one functional group having complexing properties in the molecule of the organ-specific substance, and the other component contains a reducing agent which is required for the reduction of 99m pertechnetate and subsequent binding of technetium-99m to the pretreated organ-specific substance.
Claim 3
Dependent Claim
22 words
A test kit as claimed in claim 1, wherein the organ-specific substance is a partially reduced antibody or its F(ab') 2 fragment.
Claim 4
Dependent Claim
23 words
A test kit as claimed in claim 2, wherein the freeze-dried antibody component is mixed with disodium hydrogen phosphate as a buffer substance.
References Cited (Backward Citations)
US3903262A
Cited
US3863004A
Cited
FR2248055A1
Cited
US3928552A
Cited
US4062933A
Cited
EP0005638A2
Cited
US4187294A
Cited
US4424200A
Cited
US4478815A
Cited
EP0035765A2
Cited
US4410507A
Cited
US4479930A
Cited
US4510125A
Cited
WO1985003063A1
Cited
US4837003A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-05-26 | 1995-11-25 | 1996-05-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-05-26 | 1999-11-25 | 2000-05-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-05-26 | 2003-11-25 | 2004-05-26 | $7700.00 | Window Closed / Lapsed |